These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22147895)

  • 1. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA2 is required for lymphatic vessel valve development and maintenance.
    Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
    J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 4. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
    Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
    Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
    Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
    J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
    Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
    Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
    An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived MDS/AML in families with germline
    Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
    Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
    Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
    Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.